Abstract: Ubiquitin-conjugating (E2) enzymes in protein ubiquitination are associated with various diseases. An artificial RING finger (ARF) is a useful tool, and E2 activities are conveniently estimated based on ARF reactivities. To extend the use of ARF in cells, we constructed a TAT-ARF using a cellpenetrating trans-activator protein (TAT) peptide. An in vitro ubiquitination assay without substrates showed auto-ubiquitination of TAT-ARF via its TAT region. TAT-ARF was translocated into MCF7 breast cancer cells, and then TAT-ARF ubiquitinated itself via its ARF. Experiments using confocal laser-scanning microscopy revealed that FAM-labeled TAT-ARF was readily internalized in cells and it remained encapsulated in vesicles. The Cell Counting Kit-8 assay indicated that the TAT-ARF uptake occurred without cytotoxicity in MCF7 cells at concentrations below 5.0 μM. By taking advantage of TAT-ARF, we, for the first time, succeeded in detecting E2 activities in cells. Thus, the present work opens up new avenues in the investigation of protein ubiquitination.
Introduction
Protein ubiquitination is a complicated enzymatic cascade reaction consisting of ubiquitin (Ub)-activating (E1), Ub-conjugating (E2), and Ub-ligating (E3) enzymes.
1,2 RING fingers are a zinc-binding motif with eight ligands of Cys and/or His in a unique cross-brace arrangement. 3, 4 Most RING fingers function as E3 and transfer activated Ub from E2s to the ε-amino groups of a substrate Lys residue. 5 E2 activities are equivalent to the amounts of additional Ub transferred from E2 to the substrates. It has been demonstrated that E2s are associated with various cancers, such as breast carcinoma, 6,7 leukemia, 8 , and gastric cancer. 9 SIAH1 possesses an N-terminal-RING finger and belongs to the RING E3 family cooperating with E2s (UbcH5 and UbcH8). 10 SIAH1
induces a migratory cancer cell phenotype that leads to metastasis in breast cancer. 11 Among women, breast cancer is the second deadliest cancer 12 ; thus, there is growing interest in the detection of E2 activities for capturing the pathological conditions of cancers. However, it is challenging to evaluate E2 activities based on the amounts of Ub for all substrates because one E2 transfers Ub to several different kinds of substrates. 13 Also, the intermediate complex of RING E3 and E2-Ub conjugate may be implicated in Ub transfer. 14 To overcome this hurdle, we previously developed a novel molecular design for artificial RING fingers (ARFs) and a simplified detection system for E2 activities. [15] [16] [17] [18] In this study, to extend the use of ARFs in cells, we investigated the reactivities of ARFs using cellpenetrating peptides (CPPs), which are useful drug delivery carriers into target cells. 20 The present work allowed us to detect ARF reactivities in MCF7 breast cancer cells without cytotoxicity.
Materials and Methods

Peptide synthesis
ARF was designed by transplanting the active site (five residues: PKLTC) of SIAH1 RING into the scaffold sequence (Fig. 1) . The amino acid sequence of Williams-Beuren syndrome transcription factor (WSTF) PHD finger was used as the scaffold. 16 We constructed a TAT-ARF using a CPP (47-YGRKKRRQRRR-57) from a human immunodeficiency virus (HIV)-1 trans-activator protein (TAT). 21 Epsilon-aminocaproic acid (acp) was inserted as a highly flexible spacer. 22 The mutant (TAT-K/R) was designed where all Lys residues in the scaffold sequence were replaced with Arg. 
CD spectroscopy
The samples (25 μM) were prepared in Solution A. After calibration using d-camphor-10-sulfonate, the CD experiments were carried out on a JASCO J-805 spectropolarimeter with a 1-mm path length quartz cell. Spectra were obtained at room temperature from 200 to 250 nm under the conditions of a bandwidth of 1 nm and a data pitch of 1 nm at a scan speed of 50 nm/min. 23, 24 Each CD spectrum was obtained with an average of four scans. The CD data were acquired by transforming the CD signal into Figure 1 . The creation of an ARF with a CPP. ARF was designed as a chimeric finger between the SIAH1 RING finger and WSTF PHD finger that was used as a scaffold. The transplanting of the active site (red) of the RING into the scaffold sequence led to the creation of ARF. The TAT sequence was used as a CPP. The TAT-(green) fused ARF, where ε-aminocaproic acid (acp) was inserted as a highly flexible spacer, was created to promote the cell permeability of ARF. Lys residues that were replaced with Arg are shown in blue.
mean residue molar ellipticity, after subtraction of the spectrum for Solution A.
In vitro ubiquitination assay with ARF
The ubiquitination solution consisted of 20 mM TrisHCl (pH 6.8), 5 mM Mg-ATP, 1 mM dithiothreitol, 20 U/mL inorganic pyrophosphatase (Sigma, St. Louis, MO), and 50 μM ZnCl 2 containing 2.5 μM human Ub, 0.1 μM human recombinant E1 (Histagged), and 1.25 μg human recombinant UbcH5a as E2 (His-tagged). Ub, E1, and UbcH5a were purchased from Enzo Life Sciences (Farmingdale, NY). ARFs (21 μM) was added into the ubiquitination solution.
The mixtures were incubated at 37 C for 60 min, and the reaction was stopped by adding nonreducing sodium dodecyl sulfate (SDS) sample buffer. The obtained samples (13 μL) were subjected to Nu-PAGE (12% Bis-Tris gel, Invitrogen) in 2-(N-morpholino) ethanesulfonic acid (MES) buffer and transferred to a polyvinylidene difluoride (PVDF) membrane. To detect ubiquitinated products, the membrane was immunoblotted with anti-ubiquitin antibody (3933S, Cell Signaling Technology, CST) and anti-Rabbit IgG-HRP (sc-2313, Santa Cruz Biotechnology, CA). The signals emitted by Chemi-Lumi One Ultra (Nakalai Tesque, Japan) were detected using a Luminescent Image Analyzer (LAS-3000).
Cell culture MCF7 cells (originally purchased from American Type Culture Collection, Manassas, VA, USA) were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS containing 100 units/mL penicillin and 100 mg/mL streptomycin (DMEM/10% FBS) in a humidified atmosphere of 5% CO 2 at 37 C.
Detection of the ARF reactivities in MCF7 cells
MCF7 cells were plated on 10 cm dishes and cultured in DMEM/10% FBS. When the cells were grown to 80% confluency, the medium was replaced with FBSfree medium (DMEM/FBS (−)). Cells were used for experiments after 12 h of growth in DMEM/FBS (−). The ARF peptides were added to the cells. After incubation, cells were collected into 15 mL tubes with scrapers. After centrifuging at 400 g (5 min), the cells were washed twice with PBS. The cell pellets were suspended in an equal volume of Benzonase buffer (20 mM Tris-HCl [pH 8.5], 1% Triton X-100, 2 mM MgCl 2 , and 12.5 U/mL Benzonase (Sigma-Aldrich)), and kept on ice for 5 min. The cells were lysed by adding 1/10 volume of 10% SDS. The lysates were heated at 70 C for 5 min. Protein concentrations were quantified using the Bradford assay (Quick Start Bradford Dye Reagent, Bio-RAD). In total, 20 μg of protein from cell extracts were subjected to Nu-PAGE (12% Bis-Tris gel, Invitrogen) in MES buffer and transferred onto a PVDF membrane. To detect biotinylated ARFs, the membrane was reacted for 1 h with streptavidin-horseradish peroxidase solution (Vectastain ABC Elite Kit; Vector Laboratories, Burlingame, CA), and the emitted signals were detected on a LAS-3000. To detect actin as a loading control, anti-actin (sc-1616, Santa Cruz Biotechnology) was used for the primary antibody, and the anti-goat-IgG (sc-2020, Santa Cruz Biotechnology) was used for the secondary antibody.
Confocal microscopy
MCF7 cells (2 × 10 5 ) were plated on 35-mm glassbottomed dishes (Iwaki, Japan) and incubated in DMEM/10% FBS for 24 h. The cells were washed twice with the medium (DMEM/FBS (−)), and the cells were treated with FAM-Ahx-TAT-ARF. After the cells were rinsed three times with DMEM/FBS (−), the distribution of FAM-Ahx-TAT-ARF was analyzed on a confocal laser-scanning microscope (LSN510META, Carl Zeiss, Germany) equipped with a 40X objective without fixing the cells.
Cytotoxicity of ARFs
The tion was added to each well, and then the cells were cultured for 3 h at 37 C. The amount of the resulting formazan dye, produced from WST-8, is directly proportional to the number of living cells. The formazan dye was estimated from the absorbance at 450 nm.
Results and Discussion
Secondary structure of TAT-ARF
To obtain information on the secondary structure of TAT-ARF fused to the TAT sequence at the Nterminus of ARF, we measured the CD spectra in Solution A. The spectrum of TAT-ARF, characterized by double-negative minima at approximately 205 nm (π-π* transitions) and 230 nm (n-π* transitions), was similar to that of ARF (Supporting Information  Fig. S1 ). The negative amplitude of TAT-ARF at 205 nm was somewhat stronger than that of ARF, and this behavior was caused by the addition of the TAT sequence to ARF. TAT adopts a natively unfolded structure at room temperature, 25 and the content of the unordered region was possibly increased. 26 However, the addition of the TAT sequence to ARF did not cause drastic changes of the secondary structure of ARF. It was speculated that, like ARF, TAT-ARF has functional E2-binding capabilities and ubiquitination activities.
In vitro ubiquitination assay using ARFs
We tested whether TAT-ARF possesses E3 activities in substrate-independent in vitro ubiquitination. The formation of ubiquitin thioester-linked E2 conjugates could occur in the ubiquitination solution containing Ub, E1, and E2 (UbcH5a). 27 The addition of ARF in the ubiquitination solution led to the accumulation of ARF-Ub conjugates and promoted the development of ubiquitination cooperating with UbcH5a as shown in Fig. 2 . Like ARF, TAT-ARF functioned as an E3, and it ubiquitinated itself. Lys14 in the scaffold sequence is considered a crucial site for the Ub transfer. 17 However, the activities of TAT-ARF were stronger than those observed for ARF, indicating that the TAT sequences promoted Ub transfer via their Lys residues. Moreover, the K/R mutations of ARF in TAT-ARF increased ubiquitination activities, and the TAT-K/R construct also had strong activities. This is likely because the TAT sequence had a higher susceptibility to Ub transfer than the ARF sequence. Recent works have demonstrated that the addition of a tag (e.g., MBP) to an E3 disturbs ubiquitination activities due to the steric hindrance of the tag. 28 In contrast, the addition of TAT augmented the ubiquitination activities of ARF because the molecular size of TAT is much smaller than that of MBP. Thus, the addition of the TAT sequence was applicable in the development of the Ub reaction. The simultaneous Ub development on both Lys residues in the TAT sequence are unlikely, considering the space necessary for the Ub attachment. Namely, one Lys residue of TAT is a possible acceptor for the Ub transfer. In a previous study, ARFs were developed to conveniently detect E2 activities during the ubiquitination reaction. 8 E2
activities are estimated from the reactivities of ARFs, which are equivalent to the amounts of the additional Ub on ARFs. The ubiquitination activities of the TAT-K/R construct were much stronger than those of its wild type TAT-ARF. Thus, the TAT-K/R construct was more useful than ARF in the highly sensitive detection of E2 activities.
Reaction characteristics of TAT-ARFs in cancer cells
The cellular uptake and intracellular distributions of TAT-ARFs were tested using MCF7 cells. After treatment with biotinylated TAT-ARF (50 μM), the cells were incubated for 3 and 24 h. The TAT-ARF reactivities were detected by western blot analyses (Fig. 3A) .
The products corresponding to mono-ubiquitinated TAT-ARF (TAT-ARF-Ub) preferentially were observed at 3 h after treatment with TAT-ARF. The increasing activity of ARF was demonstrated at 24 h after treatment with TAT-ARF. Moreover, in cells following treatment with various concentrations (5, 25, and 50 μM) of TAT-ARF, reactivities were induced in a concentration-dependent manner. These data clearly provide evidence for TAT-ARF uptake. In the case of ubiquitination experiments using an anti-Ub antibody, the detection of TAT-ARF-Ub was difficult under the present conditions due to the existence of many ubiquitinated endogenous proteins in the cells (Supporting information Fig. S2) . Thus, the results showed that the utilization of the biotin tag for TAT-ARF was applicable to the simplified observation of its reactivities. The mutation (TAT-K/R) of Lys residues with Arg residues in the scaffold sequence completely abolished the ARF activities at 3 and 20 h (Fig. 3B) . The results showed that TAT-ARF in cells was ubiquitinated via its Lys residue of ARF. Thus, Lys residues of ARF in cells, but not the TAT sequence, were possible acceptors for the Ub attachment. Because the susceptibility for the Ub attachment of ARF was lower than that of TAT, the reactivities of TAT-ARF in cells was lower than those obtained in the purified assay system. In contrast, instead of ARF, TAT accepted the Ub transfer of TAT-ARF in the purified assay system described above. Notably, these data indicated that the reactivities of TAT-ARF in cells did not agree with those in the purified assay system. There is a growing interest Figure 2 . Ubiquitination activities of ARF and TAT-ARF. ARF, TAT-ARF, and TAT-K/R were added to the substrateindependent in vitro ubiquitination reaction containing ubiquitin (Ub), E1, and E2 (UbcH5a). Analyses were performed in the absence or presence of ARF, TAT-ARF, and TAT-K/R. The obtained samples were subjected to Nu-PAGE (12%). ARF, TAT-ARF, and TAT-K/R promoted auto-ubiquitinations. The Ub chains on the PVDF membrane were reacted with Ub antibody and developed with ECL reagent. The emitted signals were detected on a LAS-3000.
in unraveling these discordances, and thus the internalization pattern of TAT-ARF was examined using confocal laser microscopy (Supporting information Fig. S3 ). The cells following treatment with fluorescently labeled FAM-Ahx-TAT-ARF were incubated for 4 and 20 h. Dot-like fluorescent signals were observed in most cells, and most of the signals were not dispersed in the cytosol. TAT enters cells by micropinocytosis, 21 whereby TAT-ARF was internalized and accumulated mainly in vesicles. The TAT-ARF remained encapsulated for at least 20 h. Recent studies using atomistic molecular dynamics simulations demonstrated that TAT peptides could be buried in the hydrophobic core of bilayers. 29 Thus, the region of TAT may remain inserted in the endosomes, and not assume the role of a possible acceptor of Ub transfer. It has been demonstrated that ubiquitination is associated with endocytic sorting machineries. 30 Ubiquitinated membrane proteins are recruited into endosomes and their signaling is regulated by endocytosis. Also, some E2s are located in membrane ruffles and are involved in the ubiquitination reaction related to endocytosis. 31, 32 The ubiquitination of TAT-ARF was developed in vesicles under present conditions, and thus it could be taken into endosomes together with some ubiquitinated E2s. The utilization of TAT-ARF allowed us to measure E2 activities in endosomes based on the reactivities of ARF. At present, detection of E2 activities in endosomes is challenging, and relationships between E2 activities and endocytosis remain poorly understood. Thus, the present work opens up new avenues in the investigation of protein ubiquitination.
Cytotoxicity of TAT-ARF to cancer cells
To test the cytotoxicity of TAT-ARF, CCK-8 assays were performed using MCF7 cells. After treatment with TAT-ARF (0.5-50 μM), the number of living cells was estimated from the absorbance of the formazan dye at 450 nm. As for the relative viability, there were no change in MCF7 cells following treatment with TAT-ARF concentrations below 5 μM (Supporting information Fig. S4 ). However, the number of living cells was drastically decreased with a concentration of 50 μM. TAT-ARF has potential anticancer activities; however, its effects were much lower than those of known drugs with CPPs. 33 These results indicate that TAT-ARF (≤5 μM) penetrated cancer cells without cytotoxic effects. The aim of this study was to detect the ARF reactivities in cells. MCF7 cells treated with TAT-ARF were used as a model for capturing E2 activities. A concentration of 5 μM of TAT-ARF seemed to be appropriate for E2 detection for at least present conditions, although more precise analyses will be required. This work revealed that the ARF system is applicable for the detection of E2 activities during protein ubiquitination in cancer cells. The system is a novel technology for measuring E2 activities, however further quantitative evaluation of E2 activities based on ARF reactivities will be required in cells.
In conclusion, to the best of our knowledge, this is the first demonstration of the detection of E2 activities during ubiquitination in living cells. We designed TAT-ARF fused to the TAT sequence at the N-terminus of ARF. TAT-ARF possessed ubiquitination activities, which cooperated with E2 (UbcH5). The replacement of Lys residues with Arg residues (TAT-K/R construct) demonstrated increasing ubiquitination activities. In cancer cells, the use of TAT-ARF allowed us to detect cellular E2 activities without cytotoxic effects. Future experiments using various cancer cell lines will add credibility to the ARF methodology in detecting E2 activities. , and 50 μM) and (B) biotinylated TAT-ARF and TAT-K/R (5 μM) were added to MCF7 cancer cells in serum-free medium. After incubation, SDS lysate was prepared. The cell lysates were subjected to Nu-PAGE (12%). Western blot was performed with streptavidin-conjugated horseradish peroxidase (Vectastain ABC Elite Kit), and the reactivities of TAT-ARF and TAT-K/R were detected with a LAS-3000. TAT (5 μM) was used as a control.
